Literature DB >> 10862073

Hospital response to DRG refinements: the impact of multiple reimbursement incentives on inpatient length of stay.

B H Gilman1.   

Abstract

Recent research has warned that the introduction of Diagnosis Related Groups (DRGs) based on hospital treatment decisions will lead to an increase in the rate of marginal procedures and to a resumption of high medical expenditure growth rates. This paper explores the often contradictory effects of the multiple reimbursement incentives created by refinements to the Prospective Payment System (PPS) (principally, the introduction of procedure-based DRGs) on hospital resource allocation. Three effects are examined in the paper: (i) the change in primary or payment-related procedures owing to marginal reimbursement incentives; (ii) the change in secondary or non-payment-related services owing to average price incentives; and (iii) the change in average severity of both medical and surgical admissions. The model suggests that the anticipated positive effect of marginal reimbursement incentives on overall hospital resource use may be offset by several factors, most notably the lower average payment incentives of non-procedural DRGs. Copyright 2000 John Wiley & Sons, Ltd.

Mesh:

Year:  2000        PMID: 10862073     DOI: 10.1002/1099-1050(200006)9:4<277::aid-hec513>3.0.co;2-1

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  5 in total

1.  Has DRG payment influenced the technical efficiency and productivity of diagnostic technologies in Portuguese public hospitals? An empirical analysis using parametric and non-parametric methods.

Authors:  C E Dismuke; V Sena
Journal:  Health Care Manag Sci       Date:  1999-05

2.  Prospective funding of general hospitals in Norway--incentives for higher production?

Authors:  Egil Kjerstad
Journal:  Int J Health Care Finance Econ       Date:  2003-12

3.  Comparing the financial risk of bed-day and DRG based pricing types using parametric and simulation methods.

Authors:  Hennamari Mikkola; Reijo Sund; Miika Linna; Unto Häkkinen
Journal:  Health Care Manag Sci       Date:  2003-05

Review 4.  Linezolid: a pharmacoeconomic review of its use in serious Gram-positive infections.

Authors:  Greg L Plosker; David P Figgitt
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

5.  The effect of activity-based financing on hospital length of stay for elderly patients suffering from heart diseases in Norway.

Authors:  Jun Yin; Hilde Lurås; Terje P Hagen; Fredrik A Dahl
Journal:  BMC Health Serv Res       Date:  2013-05-07       Impact factor: 2.908

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.